• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Thorac Med . Risk factors predicting disease severity and mortality in coronavirus disease 2019 Saudi Arabian patients

tetano

Editor, Senior Moderator
Ann Thorac Med


. 2023 Apr-Jun;18(2):98-102.
doi: 10.4103/atm.atm_435_22. Epub 2023 Apr 25. Risk factors predicting disease severity and mortality in coronavirus disease 2019 Saudi Arabian patients

Wala M Al Balwi[SUP] 1 [/SUP], Nouf AlGhamdi[SUP] 1 [/SUP], Reem Alshahrani[SUP] 1 [/SUP], Ihssan H Abdelrahman[SUP] 1 2 [/SUP], Sami Mahmoud[SUP] 3 [/SUP], Ali Al-Hamad[SUP] 3 [/SUP], Salma Al Hamzah[SUP] 3 [/SUP], Fahad Al Jraid[SUP] 3 [/SUP], Maha Al Turki[SUP] 1 2 [/SUP], Mohammed A Al Balwi[SUP] 2 3 4 [/SUP]



Affiliations
Abstract

Context: Coronavirus disease 2019 (COVID-19) became a global pandemic that may be associated with significant associated risk factors.
Aims: The aim of this study was to evaluate the factors predisposing risk to death in COVID-19 patients.
Settings and design: This is a retrospective study that presents the demographic, clinical presentation, and laboratory findings on our patients to determine risk factors contributing to their COVID-19 outcome.
Methods: We used logistic regression (odds ratios) to examine associations between clinical findings and risk of death in COVID-19 patients. All analyses were done using STATA 15.
Results: A total of 206 COVID-19 patients were investigated, 28 of them died, and 178 survived. Expired patients were older (74.04 ± 14.45 vs. 55.56 ± 18.41 in those who survived) and mainly of male gender (75% vs. 42% in those who survived). The following factors were strong predictors of death: hypertension (OR: 5.48, 95% CI: 2.10-13.59, P < 0.001), cardiac disease (OR: 5.08, 95% CI: 1.88-13.74, P = 0.001), and hospital admission (OR: 39.75, 95% CI: 5.28-299.12, P < 0.001). In addition, blood group B was more frequent in expired patients (OR: 2.27, 95% CI: 0.78-5.95, P = 0.065).
Conclusions: Our work adds to the current knowledge about the factors predisposing to death in COVID-19 patient. In our cohort, expired patients were of older age and male gender plus they were more likely to have hypertension, cardiac disease, and hospital severe disease. These factors might be used to evaluate risk of death in patients recently diagnosed of COVID-19.

Keywords: Coronavirus disease 2019; Saudi; mortality; risk factors.

 
Back
Top Bottom